Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Capmatinib dihydrochloride | 1197376-85-4 | 99.8% | C23H19Cl2FN6O | 10MG
Supplier: Medchemexpress LLC HY13404A10MG
Capmatinib dihydrochloride is the dihydrochloride salt of capmatinib, a potent, selective, ATP-competitive inhibitor of the c-Met (HGFR) tyrosine kinase. Supplied as a research-grade solid, it is intended for in vitro and preclinical oncology studies and is accompanied by supplier analytical data documenting high purity and activity.
- Selective, ATP-competitive c-Met (HGFR) kinase inhibitor.
- Very high in vitro potency (IC50 = 0.13 nM against c-Met).
- High purity suitable for research (reported ~99.8%).
- Suitable for in vitro and preclinical oncology assays.
- Available as small-scale solid quantities for laboratory use.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?